Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
D.R. Horton
DHI
Lennar Corp
LEN
Vale SA
VALE
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 138.385
- -1.925-1.37%
Trading Dec 27 11:50 ET
8.28BMarket Cap-17.80P/E (TTM)
141.250High137.630Low35.03KVolume139.745Open140.310Pre Close4.88MTurnover0.06%Turnover RatioLossP/E (Static)59.80MShares161.00052wk High-81.59P/B8.21BFloat Cap111.09052wk Low--Dividend TTM59.36MShs Float183.980Historical High--Div YieldTTM2.58%Amplitude11.920Historical Low139.336Avg Price1Lot Size
Ascendis Pharma A/S Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.92%-101.58M | 5.72%-467.36M | 70.03%-42.47M | -26.19%-124.72M | -23.10%-153.13M | -12.43%-147.04M | -18.69%-495.7M | -14.90%-141.69M | -1.35%-98.83M | -7.98%-124.39M |
| Net income from continuing operations | -18.14%-131.04M | 17.45%-481.45M | 58.11%-86.88M | 3.99%-162.22M | -49.33%-121.43M | 11.62%-110.91M | -52.04%-583.19M | -95.56%-207.42M | -110.28%-168.96M | 39.48%-81.32M |
| Operating gains losses | 357.13%5.71M | 3.84%18.4M | -63.21%2.93M | 82.81%6.77M | 531.36%7.45M | -74.39%1.25M | 247.16%17.72M | 7.68%7.96M | -3.89%3.71M | -75.50%1.18M |
| Depreciation and amortization | -1.52%4.48M | 5.31%18.91M | 7.33%4.98M | 5.05%4.74M | 5.78%4.65M | 2.97%4.55M | 16.68%17.96M | 8.49%4.64M | 19.35%4.52M | 21.30%4.39M |
| Deferred tax | 93.37%2.51M | 35.82%7.3M | 8.24%5.79M | 486.23%645K | -832.61%-429K | 438.17%1.3M | 1,565.12%5.38M | 4,792.11%5.35M | -2,883.33%-167K | 32.35%-46K |
| Other non cash items | 235.94%48.82M | 49.40%-2.15M | -11.10%40.97M | -2.36%19.81M | 56.66%-27.02M | -333.84%-35.91M | 92.71%-4.24M | 419.74%46.09M | 196.42%20.28M | -645.94%-62.34M |
| Change In working capital | -116.00%-51.84M | -700.08%-99.79M | -587.30%-15.21M | -196.53%-24.03M | -478.67%-36.54M | 16.79%-24M | 73.86%-12.47M | 92.34%-2.21M | 241.04%24.9M | 63.77%-6.32M |
| -Change in receivables | -17.46%-11.29M | -184.22%-32.77M | -56.18%-8.52M | -3,499.73%-13.54M | 66.36%-1.11M | -299.17%-9.61M | -73.16%-11.53M | -307.02%-5.46M | 92.85%-376K | 20.60%-3.29M |
| -Change in inventory | -17.70%-23.75M | -41.60%-78.26M | 25.84%-19.8M | -699.28%-21.21M | -92.08%-17.07M | -18.48%-20.18M | 26.71%-55.27M | -32.59%-26.7M | 95.20%-2.65M | ---8.89M |
| -Change in prepaid assets | 61.64%-3.9M | -78.08%-11.41M | -310.37%-5.18M | 751.69%6.54M | 62.32%-2.6M | -273.02%-10.18M | 42.97%-6.41M | 182.22%2.46M | 285.51%768K | -6.24%-6.91M |
| -Change in payables and accrued expense | -233.64%-19.03M | -92.27%3.55M | -142.93%-10.05M | -70.57%4.29M | -140.01%-4.92M | 428.17%14.24M | 17.24%45.94M | 254.90%23.42M | -66.43%14.57M | 284.35%12.3M |
| -Change in other working capital | 254.72%6.13M | 29.16%19.11M | 597.00%28.34M | -100.91%-115K | -2,392.81%-10.85M | 173.87%1.73M | 131.32%14.79M | -39.51%4.07M | 11,652.29%12.59M | 533.94%473K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 30.92%-101.58M | 5.72%-467.36M | 70.03%-42.47M | -26.19%-124.72M | -23.10%-153.13M | -12.43%-147.04M | -18.69%-495.7M | -14.90%-141.69M | -1.35%-98.83M | -7.98%-124.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -96.60%7.16M | 364.06%286.47M | 934.50%6.65M | 57.60%22.22M | 374.89%46.96M | 446.54%210.65M | 155.83%61.73M | 99.29%-797K | -30.98%14.1M | -10.39%9.89M |
| Net PPE purchase and sale | 81.66%-199K | 51.74%-2.39M | 101.80%68K | 70.60%-930K | -122.03%-444K | -4,420.83%-1.09M | 79.10%-4.95M | 21.16%-3.78M | 72.01%-3.16M | 156.25%2.02M |
| Net intangibles purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | -96.53%7.35M | 333.17%288.87M | 120.54%6.58M | 34.11%23.15M | 502.07%47.4M | 449.01%211.73M | 187.56%66.69M | 102.79%2.99M | -45.59%17.26M | -46.14%7.87M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -96.60%7.16M | 364.06%286.47M | 934.50%6.65M | 57.60%22.22M | 374.89%46.96M | 446.54%210.65M | 155.83%61.73M | 99.29%-797K | -30.98%14.1M | -10.39%9.89M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,724.36%18.42M | -66.15%134.29M | -548.85%-6.06M | 188,728.95%143.36M | -3.31%-2.31M | -100.18%-702K | 12.92%396.77M | 106.54%1.35M | -100.02%-76K | -260.68%-2.24M |
| Net issuance payments of debt | -8.49%-2.79M | -74.68%125.82M | -251.94%-6.26M | 9,800.42%137.16M | -5.49%-2.52M | -100.51%-2.57M | 7,829.43%496.93M | -15.22%-1.78M | 6.61%-1.41M | -69.34%-2.39M |
| Net common stock issuance | ---- | --0 | --0 | ---- | ---- | ---- | -130.41%-105.31M | 99.99%-2K | -100.00%1K | ---150K |
| Proceeds from stock option exercised by employees | 1,036.60%21.21M | 99.61%10.29M | -35.53%2.02M | 363.28%6.19M | -30.90%208K | 384.68%1.87M | -55.34%5.15M | 34.45%3.13M | -69.80%1.34M | -89.25%301K |
| Net other financing activities | ---- | ---1.81M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,724.36%18.42M | -66.15%134.29M | -548.85%-6.06M | 188,728.95%143.36M | -3.31%-2.31M | -100.18%-702K | 12.92%396.77M | 106.54%1.35M | -100.02%-76K | -260.68%-2.24M |
| Net cash flow | ||||||||||
| Beginning cash position | -11.83%392.16M | -0.34%444.77M | -27.46%441.27M | -41.37%394.22M | -33.66%501.28M | -0.34%444.77M | -23.65%446.27M | -12.21%608.33M | 74.86%672.39M | 52.64%755.64M |
| Current changes in cash | -220.83%-76M | -25.28%-46.6M | 70.33%-41.87M | 148.18%40.86M | 7.08%-108.48M | -79.41%62.9M | 78.97%-37.19M | 44.84%-141.13M | -128.89%-84.81M | -13.59%-116.74M |
| Effect of exchange rate changes | 163.87%4.08M | -116.83%-6.01M | 67.77%-7.23M | -70.19%6.19M | -95.76%1.42M | -264.29%-6.39M | -7.51%35.69M | -344.12%-22.43M | 39.38%20.75M | 533.00%33.48M |
| End cash Position | -36.12%320.24M | -11.83%392.16M | -11.83%392.16M | -27.46%441.27M | -41.37%394.22M | -33.66%501.28M | -0.34%444.77M | -0.34%444.77M | -12.21%608.33M | 74.86%672.39M |
| Free cash flow | 31.29%-101.78M | 7.92%-469.8M | 70.85%-42.41M | -23.24%-125.7M | -19.87%-153.57M | -10.05%-148.13M | -15.46%-510.19M | -13.55%-145.47M | 6.27%-102M | -7.86%-128.12M |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.